5 Jul 2024 | News
Recently, Technophage CEO Miguel Garcia, attended the prestigious JLABS EMEA CEO Summit 2024. This event, held in the exciting city of London, brought together leaders from the biotech and life sciences industries. It is an incredible platform for collaboration,...
25 Jun 2024 | News
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2024’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC Innovative Status...
27 Nov 2023 | News
For eight years in a row, the Healthcare & Pharmaceutical Awards have recognized the pioneers transforming our healthcare field. We are thrilled to announce that Technophage has been recognized as the “Most Innovative Biopharmaceutical Company 2023 –...
3 Nov 2023 | News
Technophage is thrilled to share that TZ-161 product is now one step closer to potentially becoming a pioneering repurposed treatment for patients suffering from acute spinal cord injury. This innovative product, currently undergoing clinical trial application in...
22 Set 2023 | News
Miguel Garcia, the CEO of Technophage S.A. and LxBio – Pharmaceuticals S.A., recently presented the Bio-Hub Project during the First Annual Meeting of Mobilizing and Green Agendas for Business Innovation, as part of the Recovery and Resilience Plan (PRR). The...
20 Set 2023 | News
This week marked an important occasion as Technophage and VectorB2B – Drug Development joined forces for our annual Teambuilding event. Our destination was the picturesque town of Dornes, where a selection of thrilling team challenges awaited us. Both teams...
